On November 23, 2020 RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, reported that it will present and participate at the following virtual conferences in December (Press release, RedHill Biopharma, NOV 23, 2020, View Source [SID1234571566]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Evercore ISI 3rd Annual HealthCONx Conference
Fireside chat and an open Q&A: Thursday, December 3, 2020, 8 a.m. EST
Moderator: Umer Raffat, Equity Research – Biotech-large, Pharma-major, Specialty Pharma
Speaker: Dror Ben-Asher, CEO & Gilead Raday, Chief Operating Officer
Piper Sandler 32nd Annual Virtual Healthcare Conference
Fireside chat: Available on-demand from November 23, 2020
Moderator: David Amsellem, Managing Director, Sr. Research Analyst, Specialty Pharma
Speaker: Guy Goldberg, Chief Business Officer
The webcasts will be available for replay for 30 days on the Company’s website: View Source